While currently available percutaneous arteriovenous fistula (pAVF) devices have demonstrated a high rate of technical procedural success, secondary interventions are often required to achieve fistula maturation with these devices. CLICK HERE to read an excellent...
During the recent Charing Cross (CX) International Symposium held in London, Robert Shahverdyan, MD detailed the challenges associated with the use of current endovascular arteriovenous fistula (endoAVF) devices and provided insights from his clinical experience with...
Venova Medical will be attending the 2023 Charing Cross Symposium (CX). Contact us to arrange a meeting with a member of our team to learn more about the Velocity™ System and the company’s efforts. Meeting website:...
Venova Medical will be attending the 13th Congress of the Vascular Access Society. Contact us to arrange a meeting with a member of our team to learn more about the Velocity™ System and the company’s efforts. Meeting website: https://vas2023.com/...
